Column Capital Advisors’s Calumet Specialty Products CLMT Stock Holding History

Column Capital Advisors’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.24M	Buy	65,010 +10	+0%	+$173	0.18%	54
2023 Q2	$1.03M	Sell	65,000 -638	-1%	-$10.5K	0.14%	60
2023 Q1	$1.14M	Buy	65,638 +638	+1%	+$11.3K	0.17%	56
2022 Q4	$1.1M	Hold	65,000	–	–	0.18%	52
2022 Q3	$833K	Hold	65,000	–	–	0.17%	52
2022 Q2	$675K	Hold	65,000	–	–	0.13%	54
2022 Q1	$885K	Hold	65,000	–	–	0.16%	54
2021 Q4	$858K	Buy	65,000 +18,455	+40%	+$232K	0.17%	55
2021 Q3	$368K	Hold	46,545	–	–	0.08%	82
2021 Q2	$320K	Buy	+46,545	New	+$287K	0.07%	86

Other funds holding CLMT

AAA

Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return

DMKJ

David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FMI

F/M Investments Washington, District of Columbia $1.97B AUM 30.33% 1-Year Est. Return

JCP

Jennifer C. Price $75.5M AUM 6.25% 1-Year Est. Return

WWM

Windsor Wealth Management Indianapolis, Indiana $546M AUM 16.47% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BCM

Bienville Capital Management New York $750M AUM 2.59% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Column Capital Advisors's CLMT Position: Q3 2023 in Review

Column Capital Advisors increased its Calumet Specialty Products (CLMT) stake by 0.02% in Q3 2023, buying an estimated $173 and bringing the position to 65,010 shares worth $1.24M. The position accounts for 0.18% of the portfolio, ranked #54.

Column Capital Advisors first reported a position in CLMT in Q2 2021 and has held it in 10 quarters since. 69 funds tracked by Wall St. Rank hold CLMT as of Q3 2023.

Column Capital Advisors held 65,010 shares of Calumet Specialty Products worth $1.24M as of Q3 2023.
Column Capital Advisors bought 10 Calumet Specialty Products shares in Q3 2023, an estimated $173.
Calumet Specialty Products made up 0.18% of Column Capital Advisors's portfolio in Q3 2023, its #54 holding.
Column Capital Advisors first reported a position in Calumet Specialty Products in Q2 2021 and has held it in 10 quarters since.
69 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.